Hybrid IgE-IgG1 antibodies (IgEG): a new antibody class that combines IgE and IgG functionality
IgG-based anti-cancer therapies have achieved promising clinical outcomes, but, especially for patients with solid tumors, response rates vary. IgE antibodies promote distinct immune responses compared to IgG and have shown anti-tumoral pre-clinical activity and preliminary efficacy and safety profi...
Збережено в:
| Автори: | , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Taylor & Francis Group
2025-12-01
|
| Серія: | mAbs |
| Предмети: | |
| Онлайн доступ: | https://www.tandfonline.com/doi/10.1080/19420862.2025.2502673 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|